Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$64.17−0.15 (-0.23%)
Close on Nov 12, 2026Market cap $3.14BP/E –Yield –
Celcuity cash
Cash and short-term investments held at the end of each period.
Celcuity's cash was $642.70M at Sep 30, 2026. For fiscal 2025 it was $441.50M, up 87.8% from the year before. Over ten years it grew 56.3% a year on average. The highest annual figure on record is $441.50M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $441.50M | +87.8% |
| FY2024 | Dec 31, 2024 | $235.10M | +30.2% |
| FY2023 | Dec 31, 2023 | $180.58M | +7.1% |
| FY2022 | Dec 31, 2022 | $168.59M | +100.0% |
| FY2021 | Dec 31, 2021 | $84.29M | +624.2% |
| FY2020 | Dec 31, 2020 | $11.64M | -37.9% |
| FY2019 | Dec 31, 2019 | $18.74M | -24.8% |
| FY2018 | Dec 31, 2018 | $24.90M | +2.7% |
| FY2017 | Dec 31, 2017 | $24.25M | +310.5% |
| FY2016 | Dec 31, 2016 | $5.91M | +16.6% |
| FY2015 | Dec 31, 2015 | $5.07M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $642.70M | +41.3% |
| Q2 FY2026 | Jun 30, 2026 | $754.00M | +347.8% |
| Q1 FY2026 | Mar 31, 2026 | $387.06M | +88.2% |
| Q4 FY2025 | Dec 31, 2025 | $441.50M | +87.8% |
| Q3 FY2025 | Sep 30, 2025 | $454.98M | +72.3% |
| Q2 FY2025 | Jun 30, 2025 | $168.39M | -40.5% |
| Q1 FY2025 | Mar 31, 2025 | $205.69M | +15.8% |
| Q4 FY2024 | Dec 31, 2024 | $235.10M | +30.2% |
| Q3 FY2024 | Sep 30, 2024 | $264.06M | +97.1% |
| Q2 FY2024 | Jun 30, 2024 | $283.07M | +93.6% |
| Q1 FY2024 | Mar 31, 2024 | $177.66M | +12.8% |
| Q4 FY2023 | Dec 31, 2023 | $180.58M | +7.1% |
| Q3 FY2023 | Sep 30, 2023 | $133.94M | +133.0% |
| Q2 FY2023 | Jun 30, 2023 | $146.24M | +118.6% |
| Q1 FY2023 | Mar 31, 2023 | $157.48M | +101.1% |
| Q4 FY2022 | Dec 31, 2022 | $168.59M | +100.0% |
| Q3 FY2022 | Sep 30, 2022 | $57.48M | -36.4% |
| Q2 FY2022 | Jun 30, 2022 | $66.91M | +60.7% |
| Q1 FY2022 | Mar 31, 2022 | $78.30M | +124.1% |
| Q4 FY2021 | Dec 31, 2021 | $84.29M | +624.2% |
| Q3 FY2021 | Sep 30, 2021 | $90.37M | +559.8% |
| Q2 FY2021 | Jun 30, 2021 | $41.64M | +169.8% |
| Q1 FY2021 | Mar 31, 2021 | $34.94M | +107.3% |
| Q4 FY2020 | Dec 31, 2020 | $11.64M | -37.9% |
| Q3 FY2020 | Sep 30, 2020 | $13.70M | -33.0% |
| Q2 FY2020 | Jun 30, 2020 | $15.43M | -30.2% |
| Q1 FY2020 | Mar 31, 2020 | $16.85M | -28.0% |
| Q4 FY2019 | Dec 31, 2019 | $18.74M | -24.8% |
| Q3 FY2019 | Sep 30, 2019 | $20.45M | -10.2% |
| Q2 FY2019 | Jun 30, 2019 | $22.11M | +2.6% |
| Q1 FY2019 | Mar 31, 2019 | $23.42M | +1.8% |
| Q4 FY2018 | Dec 31, 2018 | $24.90M | +2.7% |
| Q3 FY2018 | Sep 30, 2018 | $22.76M | -30.1% |
| Q2 FY2018 | Jun 30, 2018 | $21.56M | +97.6% |
| Q1 FY2018 | Mar 31, 2018 | $23.00M | +369.6% |
| Q4 FY2017 | Dec 31, 2017 | $24.25M | +310.5% |
| Q3 FY2017 | Sep 30, 2017 | $32.55M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.91M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.91M | – |
See a number that looks wrong?